What are the recommended antibiotics for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Cellulitis Treatment

For uncomplicated cellulitis, cephalexin 500 mg orally 4 times daily for 5-7 days is the first-line treatment, with alternatives including dicloxacillin, clindamycin, or amoxicillin-clavulanate. 1

Treatment Algorithm Based on Severity

Mild Cellulitis (limited area, no systemic symptoms)

  • First-line: Cephalexin 500 mg orally 4 times daily for 5-7 days 1
  • Alternatives:
    • Dicloxacillin
    • Clindamycin (300-450 mg orally three times daily)
    • Amoxicillin-clavulanate (875/125 mg twice daily)

Moderate Cellulitis (more extensive or with systemic symptoms)

  • First-line: Cephalexin 500 mg orally 4 times daily for 7-10 days 1
  • If MRSA suspected: Add or substitute trimethoprim-sulfamethoxazole or clindamycin

Severe Cellulitis (extensive area, significant systemic symptoms)

  • Hospitalization with IV antibiotics 1:
    • Vancomycin
    • Linezolid
    • Daptomycin
  • Empiric broad-spectrum coverage: Vancomycin plus piperacillin-tazobactam or a carbapenem

When to Suspect MRSA

Consider MRSA coverage if:

  • History of prior MRSA infection
  • Purulent drainage
  • Failure to respond to beta-lactam therapy within 48-72 hours
  • Patient is in a high-risk group: athletes, children, men who have sex with men, prisoners, military recruits, residents of long-term care facilities, intravenous drug users 2

Evidence Considerations

The Infectious Diseases Society of America (IDSA) guidelines strongly recommend cephalexin as first-line therapy for non-purulent cellulitis 1. This is based on the fact that most cases of cellulitis are caused by beta-hemolytic Streptococcus and methicillin-susceptible Staphylococcus aureus (MSSA) 2.

Research has shown that in areas with high MRSA prevalence, trimethoprim-sulfamethoxazole had higher success rates (91%) compared to cephalexin (74%) 3. However, the IDSA still recommends reserving MRSA coverage for specific situations rather than as first-line empiric therapy for all cellulitis cases 1.

Important Clinical Pearls

  • Reevaluate patients within 48-72 hours to assess treatment response 1
  • Elevation of the affected area reduces edema and aids healing 1
  • Keep the area clean and dry; warm compresses may promote drainage 1
  • Treatment duration: 5 days is typically sufficient, with extension if symptoms haven't improved 2
  • Address predisposing factors to minimize risk of recurrence 2

Common Pitfalls to Avoid

  • Failure to drain purulent collections when present - antibiotics alone are often insufficient for abscesses 1
  • Inappropriate antibiotic selection or inadequate duration 1
  • Missing necrotizing infections, which require immediate surgical consultation 1
  • Overuse of broad-spectrum antibiotics - vancomycin and newer agents should be reserved for severe infections or confirmed MRSA 1
  • Clindamycin carries risk of C. difficile colitis, though this is rare with short courses 1

Special Populations

  • Children under 8 years: Cephalexin is preferred over doxycycline due to risk of dental staining with tetracyclines 1
  • Beta-lactam allergy: Clindamycin 300-450mg orally three times daily for 5-6 days 1
  • If both MRSA coverage and beta-lactam allergy: TMP-SMX (1-2 DS tablets twice daily) plus metronidazole (500mg three times daily) 1

References

Guideline

Skin Infections Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.